Concepedia

Author

Hiroyu Hatano

University of California, San FranciscoORCID

Also Known As

H. Hatano, Hiroyu Hatano, Hiroyu Hatano (131626)

51

Publications

5.7K

Citations

33

H-Index

36

Concepts

All Affiliations

University of California, San FranciscoSan Francisco General HospitalSan Francisco VA Medical CenterBlood Systems Research InstituteKarolinska Institutet
HH

About

Hiroyu Hatano is an author at University of California, San Francisco specializing in medicine, hiv, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

1.9K

2

Natural Sciences

2

2

87

3

Public Health

2

2

91

4

Cell Biology

2

2

1.3K

5

Epidemiology

2

2

91

Hiroyu Hatano

×

40

Publications

5.5K

Citations

31

H-Index

YearCitations

Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

Gilad Doitsh, Nicole Galloway, Xin Geng,

Nature

2013

1.1K

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality

Sergio Serrano‐Villar, Talía Sainz, Sulggi A. Lee,

PLoS Pathogens

2014

599

Antiretroviral Therapy Initiated Within 6 Months of HIV Infection Is Associated With Lower T-Cell Activation and Smaller HIV Reservoir Size

Vivek Jain, Wendy Hartogensis, Peter Bacchetti,

The Journal of Infectious Diseases

2013

327

Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells

Hiroyu Hatano, Vivek Jain, Peter W. Hunt,

The Journal of Infectious Diseases

2012

253

The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting

Christopher D. Pilcher, Clarissa Ospina-Norvell, Aditi Dasgupta,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2016

250

HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control

Brinda Emu, Elizabeth Sinclair, Hiroyu Hatano,

Journal of Virology

2008

218

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

Timothy J. Henrich, Hiroyu Hatano, Oliver Bacon,

PLoS Medicine

2017

218

Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy

Hiroyu Hatano, Eric Delwart, Philip J. Norris,

Journal of Virology

2008

204

A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response

Hiroyu Hatano, Timothy L. Hayes, Viktor Dahl,

The Journal of Infectious Diseases

2011

194

Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial

Hiroyu Hatano, Matthew C. Strain, Rebecca Scherzer,

The Journal of Infectious Diseases

2013

174

Page 1